Status:
COMPLETED
Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases
Lead Sponsor:
Medical University of Graz
Conditions:
COVID
Eligibility:
All Genders
Brief Summary
This study aims primarily 1. to assess the frequency, nature and outcome of liver disease caused or associated with COVD-19 Furthermore, the study also aims 2. to assess the impact of COVID-19 on pat...
Detailed Description
The outbreak of the novel coronavirus (SARS-CoV-2)-infected disease (COVID-19) began in Wuhan, Hubei province in December 2019, spread throughout China in early 2020 and developed as a pandemic therea...
Eligibility Criteria
Inclusion
- Covid-19 infection treated within the KAGES (Steirische Krankenanstalten GesmBH = Styrian public hospitals)
Exclusion
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1366 Patients enrolled
Trial Details
Trial ID
NCT04420637
Start Date
June 15 2020
End Date
December 31 2022
Last Update
January 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine, Medical University of Graz
Graz, Austria, 8010